content emphas agenda chang
event close march eisai post present materi
regular media inform brief host repres
corpor offic ceo haruo naito websit cover page
featur titl ecosystem partnership innov imag
year boarsign mr naito think
imag symbol compani headlong rush reform japanes
word headlong rush incorpor chines charact boar
disclosur present start review medium-term plan
eway cover topic includ compani activ
achiev field dementia oncolog progress
toward meet eway numer target field dementia
present outlin develop progress three new alzheim
treatment candid aducanumab elenbecestat
new inform compani plan start singl phase trial
agre author month march aim
final readout primari endpoint aim
primari endpoint final readout aducanumab develop mainli
brief analyst investor schedul friday
march held media brief march compani plan hold
one analyst investor press like publish articl
base media brief march materi
contain fresh inform like prompt chang invest view
opinion particular focu scale
design phase trial
valuat metric
chang tp
number share mn
price month
price rel chart measur perform
topix close
spot exchang rate
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
profit tax
issuanc retir stock
net chang cash
number share mn
compani mention price
